Giovannni Palladini

49PUBLICATIONS
210CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersBioinformatic methods development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Jun 17, 2026
Unveiling the unseen: navigating heart involvement in amyloidosis with biomarkers beyond the horizons of imaging.

|Jun 15, 2026
A Phase 2 trial of daratumumab monotherapy in newly diagnosed patients with cardiac stage IIIb AL amyloidosis.

|May 12, 2026
Daratumumab-Bortezomib-Cyclophosphamide-Dexamethasone in Newly Diagnosed Amyloidosis: ANDROMEDA Final Survival Analysis.

|Mar 12, 2026
Blood phosphorylated tau elevation as a biomarker in immunoglobulin light chain and transthyretin amyloidosis.

Stephan A Kaeser, Stephanie A Schultz, Anna Hofmann

|Mar 11, 2026
Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers.

Carmen González, Juan-Jose Garces, Hector Gracia

|Mar 07, 2026
Predicting Early Mortality in Newly Diagnosed AL Amyloidosis: Development and Validation of the PACE Score for Daratumumab-Treated Patients.

George S Mellgard, Abdul-Hamid Bazarbachi, Saurabh Zanwar

Pageof 9

Frequent Collaborators

25 joint publications

Giampaolo Merlini

14 joint publications

Paolo Milani

10 joint publications

Efstathios Kastritis

10 joint publications

Mario Nuvolone